Back to search

Article

Serum Level of Cytokeratin 18 (M65) as Prognostic Marker of High Cardiovascular Disease Risk in Non-alcoholic Fatty Liver Disease Individuals

2023-06-23

Abstract excerpt

<h4>Background: </h4> and aim: To explore the discriminant accuracy of Cytokeratin 18 (CK18, including M65 and M30 forms) for an elevated fatty liver index (FLI) as a validated proxy of Non-Alcoholic Fatty Liver Disease (NAFLD), and cardiovascular disease (CVD) risk in the general population. <h4>Methods:</h4> Both serum CK18 forms were measured using a commercial immunoassay in randomly selected samples from 312...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f92dde18-dc39-5424-9945-4af5d02f7da1
DOI
10.20944/preprints202306.1654.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serum Level of Cytokeratin 18 (M65) as Prognostic Marker of High Cardiovascular Disease Risk in Non-alcoholic Fatty Liver Disease IndividualsDOI 10.20944/preprints202306.1654.v1
Select a neighboring publication to make it the new centre.